Ronald Blue Trust, Inc. Corcept Therapeutics Inc Transaction History
Ronald Blue Trust, Inc.
- $8.63 Billion
- Q4 2025
A detailed history of Ronald Blue Trust, Inc. transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Ronald Blue Trust, Inc. holds 1,074 shares of CORT stock, worth $81,129. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,074
Previous 1,498
28.3%
Holding current value
$81,129
Previous $124,000
34.68%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding CORT
# of Institutions
473Shares Held
80.2MCall Options Held
596KPut Options Held
710K-
Black Rock Inc. New York, NY16.5MShares$1.25 Billion0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.54MShares$720 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY7.7MShares$582 Million20.92% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.09MShares$460 Million0.72% of portfolio
-
Parallel Advisors, LLC3.87MShares$292 Million6.09% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $8.09B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...